HMGN2 and bacterial infectious disease: For therapeutic applications, future research could develop small-molecule inhibitors, epigenetic regulatory drugs, or cellular gene-editing therapies based on HMGN2 to enhance innate immunity, which can be combined with antibiotics to tackle drug-resistant bacterial infections.